Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 4125013, 10 pages
https://doi.org/10.1155/2018/4125013
Research Article

Pre- and Postoperative Body Composition and Metabolic Characteristics in Patients with Acromegaly: A Prospective Study

1Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China
2China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China
3Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China

Correspondence should be addressed to Wei Chen; nc.hcmup@wnehc and Bing Xing; moc.nuyila@liamegnibgnix

Received 30 August 2017; Revised 8 November 2017; Accepted 20 November 2017; Published 8 January 2018

Academic Editor: Andrea G. Lania

Copyright © 2018 Xiaopeng Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Katznelson, “Alterations in body composition in acromegaly,” Pituitary, vol. 12, no. 2, pp. 136–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Birzniece, A. E. Nelson, and K. K. Y. Ho, “Growth hormone and physical performance,” Trends in Endocrinology & Metabolism, vol. 22, no. 5, pp. 171–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. U. Freda, W. Shen, S. B. Heymsfield et al., “Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly,” Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 6, pp. 2334–2343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. Clemmons, “Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly,” Pituitary, vol. 5, no. 3, pp. 181–183, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Moller, O. Schmitz, J. O. Joorgensen et al., “Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy,” Journal of Clinical Endocrinology & Metabolism, vol. 74, no. 5, pp. 1012–1019, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. O'Sullivan, J. J. Kelly, D. M. Hoffman, J. Freund, and K. K. Ho, “Body composition and energy expenditure in acromegaly,” The Journal of Clinical Endocrinology & Metabolism, vol. 78, no. 2, pp. 381–386, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. T. J. Reid, Z. Jin, W. Shen et al., “IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition,” Pituitary, vol. 18, no. 6, pp. 808–819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. R.-J. M. Brummer, L. Lönn, H. Kvist, U. Grangård, B. A. Bengtsson, and L. Sjöström, “Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy,” European Journal of Clinical Investigation, vol. 23, no. 4, pp. 199–205, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Reyes-Vidal, J. C. Fernandez, J. N. Bruce et al., “Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV risk,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 11, pp. 4124–4132, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Reyes-Vidal, H. Mojahed, W. Shen et al., “Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 8, pp. 2946–2955, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Fuchtbauer, D. S. Olsson, B. A. Bengtsson, L. L. Norrman, K. S. Sunnerhagen, and G. Johannsson, “Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up,” European Journal of Endocrinology, vol. 177, no. 2, pp. 217–226, 2017. View at Publisher · View at Google Scholar
  12. W. Chen, H. Jiang, J.x. Yang et al., “Body composition analysis by using bioelectrical impedance in a young healthy Chinese population: methodological considerations,” Food and Nutrition Bulletin, vol. 38, no. 2, pp. 172–181, 2017. View at Publisher · View at Google Scholar
  13. D. R. Wagner and V. H. Heyward, “Techniques of body composition assessment: a review of laboratory and field methods,” Research Quarterly for Exercise and Sport, vol. 70, no. 2, pp. 135–149, 1999. View at Publisher · View at Google Scholar
  14. A. Bosy-Westphal, B. Schautz, W. Later, J. J. Kehayias, D. Gallagher, and M. J. Muller, “What makes a BIA equation unique? Validity of eight-electrode multifrequency BIA to estimate body composition in a healthy adult population,” European Journal of Clinical Nutrition, vol. 67, Supplement 1, pp. S14–S21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. R. Preis, J. M. Massaro, S. J. Robins et al., “Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study,” Obesity, vol. 18, no. 11, pp. 2191–2198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Brummer, B. A. Bengtsson, and I. Bosaeus, “Validation of body composition determination by bioelectrical impedance analysis in acromegaly,” European Journal of Clinical Nutrition, vol. 46, no. 1, pp. 47–52, 1992. View at Google Scholar
  17. L. Katznelson, E. R. Laws Jr, S. Melmed et al., “Acromegaly: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 11, pp. 3933–3951, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Melmed, F. F. Casanueva, A. Klibanski et al., “A consensus on the diagnosis and treatment of acromegaly complications,” Pituitary, vol. 16, no. 3, pp. 294–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhang, X. Guo, L. Pei, Z. Zhang, G. Tan, and B. Xing, “High levels of IGF-1 predict difficult intubation of patients with acromegaly,” Endocrine, vol. 57, no. 2, pp. 326–334, 2017. View at Publisher · View at Google Scholar
  20. J. O. L. Jorgensen, L. Møller, M. Krag, N. Billestrup, and J. S. Christiansen, “Effects of growth hormone on glucose and fat metabolism in human subjects,” Endocrinology and Metabolism Clinics of North America, vol. 36, no. 1, pp. 75–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. K. Ho, J. Gibney, G. Johannsson, and T. Wolthers, “Regulating of growth hormone sensitivity by sex steroids: implications for therapy,” Frontiers of Hormone Research, vol. 35, pp. 115–128, 2006. View at Publisher · View at Google Scholar
  22. A. Tchernof and J. P. Despres, “Pathophysiology of human visceral obesity: an update,” Physiological Reviews, vol. 93, no. 1, pp. 359–404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Moller, “Growth hormone and fluid homeostasis,” Frontiers of Hormone Research, vol. 33, pp. 161–184, 2005. View at Publisher · View at Google Scholar
  24. J. Moller, “Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects,” Growth Hormone & IGF Research, vol. 13, no. 2-3, pp. 55–74, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. T. B. Hansen, J. Gram, P. Bjerre, C. Hagen, and J. Bollerslev, “Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study,” Clinical Endocrinology, vol. 41, no. 3, pp. 323–329, 1994. View at Publisher · View at Google Scholar
  26. W. Liu, S. G. Thomas, S. L. Asa, N. Gonzalez-Cadavid, S. Bhasin, and S. Ezzat, “Myostatin is a skeletal muscle target of growth hormone anabolic action,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 11, pp. 5490–5496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Salomon, R. C. Cuneo, R. Hesp, J. F. Morris, L. Poston, and P. H. Sonksen, “Basal metabolic rate in adults with growth hormone deficiency and in patients with acromegaly: relationship with lean body mass, plasma insulin level and leucocyte sodium pump activity,” Clinical Science, vol. 83, no. 3, pp. 325–330, 1992. View at Publisher · View at Google Scholar
  28. J. Gibney, T. Wolthers, M. G. Burt, K. C. Leung, A. M. Umpleby, and K. K. Y. Ho, “Protein metabolism in acromegaly: differential effects of short- and long-term treatment,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 4, pp. 1479–1484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kaji, T. Sugimoto, D. Nakaoka et al., “Bone metabolism and body composition in Japanese patients with active acromegaly,” Clinical Endocrinology, vol. 55, no. 2, pp. 175–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Vestergaard and L. Mosekilde, “Fracture risk is decreased in acromegaly—a potential beneficial effect of growth hormone,” Osteoporosis International, vol. 15, no. 2, pp. 155–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. L. Ng and D. J. Evans, “Leucocyte sodium transport in acromegaly,” Clinical Endocrinology, vol. 26, no. 4, pp. 471–480, 1987. View at Publisher · View at Google Scholar · View at Scopus